311690 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
CJ Bioscience, Inc. engages in the research and development of pharmaceutical products. Its product pipeline includes CJRB-101, CJRB-201, and CJRB-203. The company was founded by Jong-Sik Chun on November 18, 2009 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
311690 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company